ICUI vs LIVN
ICUI: ICU Medical designs and distributes infusion delivery systems and critical care products for hospitals and ambulatory care providers worldwide. LIVN: LivaNova is a medical technology company specializing in innovative cardiovascular and neuromodulation therapies to improve patient lives.
Side-by-side fundamentals
| Metric | ICUI | LIVN | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $161.46 | $81.05 | |
| Market cap as of 2026-08-01 | $4.2B | $4.4B | |
| P/E as of 2026-08-01 | 90.07 | 41.29 | LIVN lower |
| PEG as of 2026-08-01 | n/a | 4.04 | |
| Net margin as of 2026-08-01 | +2.1% | +7.5% | LIVN higher |
| Gross margin as of 2026-08-01 | +37.9% | +67.5% | LIVN higher |
| Operating margin as of 2026-08-01 | +4.1% | +13.1% | LIVN higher |
| ROE as of 2026-08-01 | +2.2% | +9.1% | LIVN higher |
| ROA as of 2026-08-01 | +1.1% | +4.2% | LIVN higher |
| Debt / equity as of 2026-08-01 | 0.61 | 0.24 | LIVN lower |
| Revenue growth (YoY) as of 2026-08-01 | -10.9% | +12.4% | LIVN higher |
| Revenue CAGR (3y) SEC XBRL | -0.7% | +10.8% | LIVN higher |
| Beta as of 2026-08-01 | 0.74 | 0.88 | |
| 1-year return as of 2026-07-27 close | +24.3% | +84.2% | LIVN higher |
Fundamentals: market data, as of 2026-08-01. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.